Suppr超能文献

相似文献

1
Metabolic Phenotypes, Dependencies, and Adaptation in Lung Cancer.
Cold Spring Harb Perspect Med. 2021 Nov 1;11(11):a037838. doi: 10.1101/cshperspect.a037838.
2
Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer.
Cell Metab. 2016 Mar 8;23(3):517-28. doi: 10.1016/j.cmet.2016.01.007. Epub 2016 Feb 4.
4
Targeting metabolic reprogramming in KRAS-driven cancers.
Int J Clin Oncol. 2017 Aug;22(4):651-659. doi: 10.1007/s10147-017-1156-4. Epub 2017 Jun 24.
6
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.
Nature. 2012 Mar 18;483(7391):613-7. doi: 10.1038/nature10937.
7
Potential therapeutics using tumor-secreted lactate in nonsmall cell lung cancer.
Drug Discov Today. 2021 Nov;26(11):2508-2514. doi: 10.1016/j.drudis.2021.07.014. Epub 2021 Jul 27.
8
Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment.
Nat Rev Cancer. 2021 Aug;21(8):510-525. doi: 10.1038/s41568-021-00375-9. Epub 2021 Jul 9.
9
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma.
Biochim Biophys Acta. 2016 Dec;1866(2):177-188. doi: 10.1016/j.bbcan.2016.09.001. Epub 2016 Sep 4.

引用本文的文献

1
Targeting LKB1/STK11-mutant cancer: distinct metabolism, microenvironment, and therapeutic resistance.
Trends Pharmacol Sci. 2025 Aug;46(8):722-737. doi: 10.1016/j.tips.2025.06.008. Epub 2025 Jul 22.
2
Unravelling the Triad of Lung Cancer, Drug Resistance, and Metabolic Pathways.
Diseases. 2024 May 6;12(5):93. doi: 10.3390/diseases12050093.
3
Serine synthesis and catabolism in starved lung cancer and primary bronchial epithelial cells.
Cancer Metab. 2024 Mar 21;12(1):9. doi: 10.1186/s40170-024-00337-3.
4
Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer.
Proc Natl Acad Sci U S A. 2024 Mar 26;121(13):e2319429121. doi: 10.1073/pnas.2319429121. Epub 2024 Mar 21.

本文引用的文献

1
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1.
Nat Cancer. 2020 Jun;1(6):589-602. doi: 10.1038/s43018-020-0071-1. Epub 2020 Jun 8.
2
Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth.
Cell Metab. 2021 May 4;33(5):1013-1026.e6. doi: 10.1016/j.cmet.2021.02.001. Epub 2021 Feb 19.
3
Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis.
Cell Metab. 2021 Jan 5;33(1):174-189.e7. doi: 10.1016/j.cmet.2020.12.007. Epub 2020 Dec 22.
4
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer.
Nat Metab. 2020 Dec;2(12):1401-1412. doi: 10.1038/s42255-020-00316-0. Epub 2020 Nov 30.
5
Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis.
PLoS One. 2020 Nov 13;15(11):e0241241. doi: 10.1371/journal.pone.0241241. eCollection 2020.
7
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC).
Pharmaceuticals (Basel). 2020 Sep 25;13(10):273. doi: 10.3390/ph13100273.
8
KRAS Inhibition with Sotorasib in Advanced Solid Tumors.
N Engl J Med. 2020 Sep 24;383(13):1207-1217. doi: 10.1056/NEJMoa1917239. Epub 2020 Sep 20.
9
Mitochondrial ubiquinol oxidation is necessary for tumour growth.
Nature. 2020 Sep;585(7824):288-292. doi: 10.1038/s41586-020-2475-6. Epub 2020 Jul 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验